Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,708,956
-$16,430,534 QoQ
Shares Held
2,185,329
-61.4% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. RXRX ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,708,956 | 2,185,329 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $23,139,490 | 5,657,578 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $35,576,918 | 7,290,353 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $28,789,432 | 5,689,612 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $26,505,187 | 5,010,433 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,337,159 | 2,860,527 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $12,370,749 | 1,877,201 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $13,262,336 | 1,768,312 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $19,578,852 | 1,963,777 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $25,398,360 | 2,575,899 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,170,655 | 806,622 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,915,007 | 390,229 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,729,974 | 259,367 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,568,745 | 333,171 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,936,020 | 275,942 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,804,667 | 221,704 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,006,672 | 140,597 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,978,530 | 115,501 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $223,196 | 9,700 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,463 | 1,136 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||